Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hip Arthritis Associated With AS Efficacy and Safety of Early Treatment With Infliximab (Remicade®)

NCT01148901 is registered in ClinicalTrials.gov with Merck Sharp & Dohme LLC as lead sponsor.

NCT NCT01148901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01148901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hip Arthritis Associated With AS Efficacy and Safety of Early Treatment With Infliximab (Remicade®)
Lead sponsor
Merck Sharp & Dohme LLC
Phase
Phase 4
Overall status
Withdrawn
Start date
June 30, 2010
Completion date
December 31, 2010
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis